HS 10509
Alternative Names: HS-10509Latest Information Update: 21 Mar 2024
At a glance
- Originator Jiangsu Hansoh Pharmaceutical
- Class Antipsychotics; Neuroprotectants; Neuropsychotherapeutics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Schizophrenia